Last reviewed · How we verify
NCT04460209
EP Device Registry
trial testing Standard of Care in Cardiac Rhythm Disorder in 5,003 participants. Completed in 31 January 2026.
31 January 2026
Quick facts
| Lead sponsor | Abbott Medical Devices |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 5,003 |
| Start date | 12 June 2020 |
| Primary completion | 31 January 2026 |
| Estimated completion | 31 January 2026 |
| Sites | 26 locations across France, Italy, Netherlands, India, Austria, Germany, Hungary, Portugal |
Drugs / interventions tested
- Standard of Care
Conditions studied
- Cardiac Rhythm Disorder — all drugs for Cardiac Rhythm Disorder →
Sponsor
Abbott Medical Devices — full company profile →
Who can join
Eligibility, any sex, with Cardiac Rhythm Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will provide ongoing, high quality data on the safety, performance, and clinical benefits of Abbott's EP devices in a real-world setting.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04460209
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Standard of Care
Trials testing the same drug.
- NCT07337655 — Efficacy and Safety of Aspirin and Lansoprazole for Prevention of Preterm Birth in High-Risk Pregnant Women: A Biomarker · Phase 2, PHASE3 · not yet recruiting
- NCT07018466 — Tele-Exercise for MERP · NA · not yet recruiting
- NCT06930768 — Evaluating the Efficacy of NeoThelium FT in the Treatment of Venous Leg Ulcers · NA · not yet recruiting
- NCT06918548 — Evaluating the Efficacy of NeoThelium FT in the Treatment of Pressure Injuries · NA · not yet recruiting
- NCT07094308 — The LIFT-ECHO Last Mile Project · NA · not yet recruiting
Other recruiting trials for Cardiac Rhythm Disorder
Currently open trials in the same condition.
- NCT05694572 — Post-market Surveillance of Micorport CRM Cardiac Implantable Electronic Devices · recruiting
- NCT05788120 — Incidence and Morbidity of Cardiac Rhythm Disorders in Patients Assisted by ECMO-VA for Refractory Cardiogenic Shock · recruiting
- NCT04559945 — The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System · NA · active not recruiting
Other Abbott Medical Devices trials
Trials by the same sponsor.
- NCT07421076 — Grid eXplore Mapping Study · NA · recruiting
- NCT07509658 — TriClip Japan Post-Approval Study · recruiting
- NCT07361445 — Agilis RF TSP Early Feasibility Study · NA · recruiting
- NCT07373353 — A Clinical Evaluation of AMJ-401 · NA · recruiting
- NCT07217392 — Left Bundle Branch Area Pacing (LBBAP) PMCF Study · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04460209 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Abbott Medical Devices
- Last refreshed: 12 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04460209.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing